LOC728024 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63236091310637E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.16624504392848E-12 |
Normal-vs-Stage2 |
1.96159999998891E-06 |
Normal-vs-Stage3 |
3.40689999989152E-07 |
Normal-vs-Stage4 |
2.33229999757611E-08 |
Stage1-vs-Stage2 |
6.272000E-01 |
Stage1-vs-Stage3 |
9.233200E-01 |
Stage1-vs-Stage4 |
9.840300E-02 |
Stage2-vs-Stage3 |
7.586800E-01 |
Stage2-vs-Stage4 |
6.551600E-02 |
Stage3-vs-Stage4 |
1.470020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.76492154224661E-12 |
Normal-vs-AfricanAmerican |
1.24690036074071E-10 |
Normal-vs-Asian |
1.7685899999953E-05 |
Caucasian-vs-AfricanAmerican |
7.184800E-01 |
Caucasian-vs-Asian |
2.610200E-01 |
AfricanAmerican-vs-Asian |
1.828350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62458935193399E-12 |
Normal-vs-Female |
3.35510000004646E-07 |
Male-vs-Female |
2.217700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.85609996658809E-09 |
Normal-vs-Extreme_Weight |
1.76236802928997E-12 |
Normal-vs-Obese |
1.75439995864224E-09 |
Normal-vs-Extreme_Obese |
6.0292999999989E-05 |
Normal_Weight-vs-Extreme_Weight |
6.283800E-01 |
Normal_Weight-vs-Obese |
4.033600E-01 |
Normal_Weight-vs-Extreme_Obese |
7.050800E-01 |
Extreme_Weight-vs-Obese |
1.089410E-01 |
Extreme_Weight-vs-Extreme_Obese |
4.589600E-01 |
Obese-vs-Extreme_Obese |
9.197000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.31420000004656E-06 |
Normal-vs-Age(41-60Yrs) |
2.86500045909577E-10 |
Normal-vs-Age(61-80Yrs) |
1.01030295240889E-14 |
Normal-vs-Age(81-100Yrs) |
6.47899999983714E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.924600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.416800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.510000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.283900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.223000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.928200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
8.80162609462332E-12 |
Normal-VS-Type2 PRCC |
1.0369483049999E-13 |
Normal-VS-KIRP CIMP |
5.83240122864481E-11 |
Normal-VS-Unclassified PRCC |
6.0032000004373E-07 |
Type1 PRCC-VS-Type2 PRCC |
2.399400E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.238270E-03 |
Type1 PRCC-VS-Unclassified PRCC |
5.072200E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.678500E-02 |
Type2 PRCC-VS-Unclassified PRCC |
1.259190E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.522680E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.34636787566478E-12 |
Normal-vs-N1 |
9.59379997667043E-09 |
Normal-vs-N2 |
2.381800E-04 |
N0-vs-N1 |
8.246600E-01 |
N0-vs-N2 |
3.984400E-01 |
N1-vs-N2 |
4.967000E-01 |
|
|